50% off all subscriptions! ... left. Order NowOrder Now

Weaker Stock
Today CBIO ranks #12183 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Catalyst Biosciences Stock Forecast NASDAQ:CBIO

$1.25 (-7.41%)

Volume: 668k

Closed: Nov 26, 2021

Hollow Logo Score: -4.567

Catalyst Biosciences Stock Forecast

$1.25 (-7.41%)

Volume: 668k

Closed: Nov 26, 2021

Score Hollow Logo -4.567
Which way will CBIO go? Request
Key Stats
P/E Ratio -0.45
Beta 0.77
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 6 and the stock is extremely oversold on RSI14, but some stocks may continue to fall despite the high chance of a correction up. The low RSI lowers the general risk and the stock should be considered if other technical requirements like liquidity and risk-reward are meet.

Catalyst Biosciences stock price took a fall of -7.41% on Friday
(Updated on Nov 26, 2021)


Sell candidate since 2021-10-15 Loss -68.75%

The Catalyst Biosciences stock price fell by -7.41% on the last day (Friday, 26th Nov 2021) from $1.35 to $1.25. During the day the stock fluctuated 8.06% from a day low at $1.24 to a day high of $1.34. The price has fallen in 8 of the last 10 days and is down by -57.48% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -68 thousand shares and in total, 668 thousand shares were bought and sold for approximately $835.13 thousand.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($1.67) are considered to be a "second chance" to get out. According to the fan-theory $0.83 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Signals & Forecast

There are few to no technical positive signals at the moment. The Catalyst Biosciences stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.33 and $2.89. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, October 14, 2021, and so far it has fallen -69.95%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.10 between high and low, or 8.06%. For the last week the stock has had a daily average volatility of 6.54%.

Catalyst Biosciences is oversold on RSI14 (6). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Catalyst Biosciences stock A Buy?

Catalyst Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.567

Predicted Opening Price for Catalyst Biosciences of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$1.28 $1.25 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 12, 2021 "Raymond James" gave "" rating for CBIO. The price target was changed from $1.71 to 41.8%.

Volatility and Risk
Daily Average Volatility: 6.54 %
Overall Risk: Very High High Medium Low Very Low
Volatility
6.54 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $1.34
Price: $1.25
No Support Found

CBIO Insider Trading Show all Trades

INSIDER POWER

11.908

Last 100 transactions
Buy: 885 934 | Sell: 74 401 (Shares)
Date Action Amount Person Type
Oct 01, 2021 Buy 3 588 Desouza Errol B Common Stock
Oct 01, 2021 Buy 1 824 Hunt Andrea Common Stock
Oct 01, 2021 Buy 5 839 Lawlor Augustine Common Stock
Oct 01, 2021 Buy 2 858 Ling Geoffrey M.d. Common Stock
Oct 01, 2021 Buy 2 980 Williams Eddie Common Stock
Show all Insider Trades
INSIDER POWER

11.908

Last 100 transactions
Buy: 885 934 | Sell: 74 401 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 1.38 10.13 %
1.34 7.08 %
1.31 5.19 %
Current price: 1.25
Support 1.24 -0.92 %
1.21 -2.81 %
1.18 -5.87 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 1.54 23.20 %
1.44 15.20 %
1.34 7.20 %
Current price 1.25
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About Catalyst Biosciences

Catalyst Biosciences Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. Its product pipeline includes CB 813d, a Factor VIIa drug candidate that completed a Phase I clinical trials evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity in severe hemophilia A... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT